Compare OLMA & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | VRTS |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 949.3M | 864.8M |
| IPO Year | 2020 | 1995 |
| Metric | OLMA | VRTS |
|---|---|---|
| Price | $7.16 | $118.87 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 12 | 4 |
| Target Price | $36.50 | ★ $136.25 |
| AVG Volume (30 Days) | ★ 1.1M | 109.4K |
| Earning Date | 11-09-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 7.97% |
| EPS Growth | 15.00 | ★ 18.24 |
| EPS | N/A | ★ 7.72 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.48 | $120.18 |
| 52 Week High | $36.26 | $183.04 |
| Indicator | OLMA | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 29.95 | 22.40 |
| Support Level | N/A | N/A |
| Resistance Level | $11.27 | $149.55 |
| Average True Range (ATR) | 0.41 | 3.99 |
| MACD | -0.06 | -0.19 |
| Stochastic Oscillator | 25.42 | 2.31 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.